Abstract

Kinsale Capital will report its quarterly results on April 23, 2026 Post Market, and this preview distills the latest consensus on revenue, profitability, and earnings alongside segment highlights and what investors should monitor into the print.

Market Forecast

Consensus points to revenue of 470.82 million US dollars for the current quarter, implying 10.67% year-over-year growth, with adjusted EPS estimated at 4.68, up 44.50% year over year, and EBIT projected at 99.20 million US dollars, up 49.17% year over year; formal gross margin and net profit margin forecasts are not available. The company’s revenue mix remains anchored by core underwriting, where the cadence of pricing, exposure growth, and claims will set the tone this quarter. Within the mix, investment income remains a promising swing factor given higher yields, complementing last quarter’s 52.30 million US dollars contribution.

Last Quarter Review

Kinsale Capital delivered revenue of 483.27 million US dollars (up 17.26% year over year), a gross profit margin of 31.16%, GAAP net profit attributable to shareholders of 139.00 million US dollars, a net profit margin of 28.68%, and adjusted EPS of 5.81 (up 25.76% year over year). A key highlight was performance above market expectations on both revenue and adjusted EPS, underscoring strong earnings power exiting the prior year. Main business highlights: net premiums contributed 415.48 million US dollars, or 85.97% of revenue, with net investment income at 52.30 million US dollars (10.82%) and fees at 10.06 million US dollars (2.08%), supporting the 17.26% overall revenue growth.

Current Quarter Outlook

Core underwriting performance and earnings trajectory

The current-quarter setup centers on how the company converts written premium growth into earned premium and operating earnings while maintaining disciplined claim costs. Consensus expects adjusted EPS of 4.68, up 44.50% year over year, which assumes solid underwriting profitability and stable expense control despite normal seasonal variability. In practical terms, the quality of top-line growth matters as much as the quantity: retention, mix, and rate adequacy will influence the underlying loss ratio and, by extension, EBIT, which is forecast to rise 49.17% year over year to 99.20 million US dollars. The recent quarter showed the model’s ability to sustain strong profitability, with a 31.16% gross margin and a 28.68% net margin. While these are not direct guides to the current quarter, they frame expectations for continued operating leverage if claims severity remains manageable and if premium rate actions are retained on renewal. Investors should assess whether new business growth is tracking alongside adequate pricing and whether the claims environment remains consistent with the company’s historical underwriting discipline. Another nuance is expense productivity. Staffing, systems, and distribution investments tend to lag top-line growth and can influence unit costs; however, scaling can offset that as earned premiums rise. If the company continues to bend the expense ratio lower through controlled growth and mix, the drop-through to EBIT and EPS can match or beat consensus. Conversely, any adverse claims trend, incremental legal/judgment costs, or one-off items could pressure margins. Management’s discussion around renewal rate change, new business contribution, and claim trends will be closely parsed for signs of persistence into midyear.

Investment income and capital deployment as incremental supports

Investment income remains a notable earnings contributor and an area with visible tailwinds from the yield backdrop. Last quarter, net investment income contributed 52.30 million US dollars (10.82% of revenue), and while mark-to-market items can introduce quarter-to-quarter noise, the base yield environment supports a firm run rate. If reinvestment rates remain constructive, investment income can cushion underwriting volatility and contribute favorably to EPS, especially with the consensus calling for a 44.50% year-over-year increase in adjusted EPS this quarter. Portfolio positioning and duration shape how quickly higher rates flow through to earnings, but even modest incremental yield capture can be meaningful at the current asset base. Management commentary on book yields, cash deployment, and any duration shifts will inform the durability of this tailwind. Short-term market volatility can affect fair-value through equity and fixed-income marks; however, the underlying net investment income line should stay resilient in the near term. Capital deployment also bears monitoring. The recent increase in the quarterly dividend to 0.25 US dollars per share signals confidence in cash generation and financial flexibility. While buybacks are not a current center of gravity, retained earnings continue to fund growth and support credit metrics. The balance between growth investment and shareholder returns can positively influence valuation if guided with clarity. Investors will look for consistency between capital allocation signals and the earnings trajectory implied by the 99.20 million US dollars EBIT estimate for the quarter.

Key stock-price drivers around the print

This quarter’s share reaction will likely hinge on the interplay between growth and profitability relative to expectations. On growth, investors will watch whether written premium momentum translates into earned revenue consistent with the 470.82 million US dollars consensus outlook and whether management implies sustained mid-teens growth through the year. Any commentary that points to normalized, not diluted, rate actions on renewals will be viewed as a constructive sign for the rest of 2026. On profitability, the market will look for stability in claims costs and evidence that any seasonal or episodic items are not recurring. A steady underlying loss ratio combined with expense discipline would validate the 49.17% year-over-year EBIT growth estimate, reinforcing confidence in margin durability. Absent a clear margin datapoint for the current quarter, investors will use qualitative signals to triangulate the trajectory—details on pricing, claims, and expense run-rates will therefore carry added weight. Finally, management tone and forward commentary will set expectations for the midyear period. Guidance around the cadence of earned premium growth, hints at rate competitiveness, and any early read on second-quarter trends could drive multiple expansion or compression. The company’s consistent beat pattern last quarter raises the bar slightly into this report, making the quality of growth a focal point for the share response. Clear articulation of how underwriting returns and investment income complement each other would strengthen the case for the 44.50% EPS growth projection to be achievable—or conservative—depending on the risk environment in the current period.

Analyst Opinions

Bullish views outnumber bearish views in our collected set (approximately 60% bullish vs 40% bearish by mention count), and the bullish camp emphasizes earnings resilience and growth visibility into 2026. Wells Fargo initiated coverage with an Overweight rating and a 490 US dollars price target, citing superior growth prospects supported by new products, a margin advantage, and conservative reserving. Truist reiterated a Buy rating during the quarter, at times citing price targets between 450 and 510 US dollars, and maintained a constructive stance on forward growth and profitability. The bullish case aligns with current-quarter forecasts that call for 10.67% revenue growth and a 44.50% year-over-year increase in adjusted EPS to 4.68, implying continued operating leverage from underwriting and support from investment income. Analysts in this camp highlight the company’s history of delivering above-expected profitability, reflected in last quarter’s 31.16% gross margin and 28.68% net margin alongside a 25.76% year-over-year gain in adjusted EPS. They expect the earnings engine to remain intact as premium growth earned through the P&L interacts with disciplined claims management and a favorable yield backdrop. Within this perspective, the primary debate is not whether the business can grow, but the slope of that growth and the sustainability of recent margin levels. Bulls generally argue that pricing remains adequate and that expense scaling should counteract growth-related costs, supporting the 99.20 million US dollars EBIT estimate this quarter. They also note that incremental investment income can absorb moderate variability in claims outcomes, which has helped the company outperform expectations in prior periods. These factors, combined with constructive capital deployment signals such as the dividend increase to 0.25 US dollars per share, underpin confidence that near-term results can meet or exceed consensus. In summary, bullish analysts see a favorable balance of growth and profitability into the upcoming print, with the potential for positive variance if underwriting margins remain steady and investment income trends continue. Their stance is supported by the company’s recent delivery—revenue of 483.27 million US dollars and adjusted EPS of 5.81 last quarter—and by forward estimates calling for double-digit revenue growth and a near mid-40% increase in EPS year over year. As a result, the prevailing institutional view in our sample is tilted to the upside ahead of April 23, 2026 Post Market.